Theravance Biopharma, Inc.Theravance Biopharma, Inc.Theravance Biopharma, Inc.

Theravance Biopharma, Inc.

No trades
See on Supercharts

Price target

14.500.000.00%
The 4 analysts offering 1 year price forecasts for TBPH have a max estimate of — and a min estimate of —.

Analyst rating

Based on 4 analysts giving stock ratings to TBPH in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


TBPH EPS for the last quarter is −0.31 USD despite the estimation of −0.20 USD. In the next quarter EPS is expected to reach 0.10 USD. Track more of Theravance Biopharma, Inc. financials and stay on top of what is up with the company.
In the next quarter Theravance Biopharma, Inc. revenue is expected to reach ‪15.50 M‬ USD. Check out Theravance Biopharma, Inc. revenue and earnings and make informed decisions.
According to analysts, TBPH price target is 14.50 USD with a max estimate of 21.00 USD and a min estimate of 10.00 USD. Check if this forecast comes true in a year, meanwhile watch Theravance Biopharma, Inc. stock price chart and keep track of the current situation with TBPH news and stock market news.